Access to anti-retroviral drugs, female in Philippines
Philippines: Access to anti-retroviral drugs, female was 21.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Philippines, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Philippines is 21.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 61.5% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Philippines peaked at 21.0% in 2020 and was at its lowest, 0.0%, in 2000.
Philippines ranks 138th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Philippines, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 3.0% | — |
| 2006 | 6.0% | +100.0% |
| 2007 | 8.0% | +33.3% |
| 2008 | 9.0% | +12.5% |
| 2009 | 9.0% | +0.0% |
| 2010 | 11.0% | +22.2% |
| 2011 | 11.0% | +0.0% |
| 2012 | 9.0% | -18.2% |
| 2013 | 12.0% | +33.3% |
| 2014 | 13.0% | +8.3% |
| 2015 | 12.0% | -7.7% |
| 2016 | 13.0% | +8.3% |
| 2017 | 15.0% | +15.4% |
| 2018 | 17.0% | +13.3% |
| 2019 | 19.0% | +11.8% |
| 2020 | 21.0% | +10.5% |
| 2021 | 21.0% | +0.0% |
| 2022 | 21.0% | +0.0% |
| 2023 | 21.0% | +0.0% |
| 2024 | 21.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.5% | 0.0% | 9.0% | 10 |
| 2010s | 13.2% | 9.0% | 19.0% | 10 |
| 2020s | 21.0% | 21.0% | 21.0% | 5 |
Countries ranked near Philippines
More gender data for Philippines
- Child population (UN estimates and projections) 28,934 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -1.61 % change on previous year (2030)
- Population 92,475 (2030)
- Working-age population (UN estimates and projections) 92,475 (2030)
- Population (UN estimates and projections), annual growth rate 1.52 % change on previous year (2030)
- Age population, age 00, female, interpolated 871,613 (2025)
- Age population, age 00, male, interpolated 935,850 (2025)
- Age population, age 01, female, interpolated 864,989 (2025)
- Age population, age 01, male, interpolated 929,411 (2025)
- Age population, age 02, female, interpolated 858,439 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Philippines?
- Access to anti-retroviral drugs, female in Philippines was 21.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Philippines?
- The highest recorded value was 21.0% in 2020.
- What is the lowest access to anti-retroviral drugs, female recorded in Philippines?
- The lowest recorded value was 0.0% in 2000.
- How does Philippines rank for access to anti-retroviral drugs, female?
- Philippines ranks 138th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Philippines?
- Over the last ten years it is up 61.5%. The long-run trend across the full record is volatile.
- Where does this Philippines data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.